V. Bi

Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys

Katherine A. Winters, C. Zhang, Y. Lau, 2009, Journal of Pharmacology and Experimental Therapeutics.

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

W. Richards, N. Hawkins, V. Shalhoub, 2012, The Journal of clinical investigation.

Mouse Monoclonal Antibodies to Transient Receptor Potential Ankyrin 1 Act as Antagonists of Multiple Modes of Channel Activation

N. Gavva, Rupa Padaki, Cherylene A Plewa, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia

Katherine A. Winters, T. Boone, R. Lindberg, 2009, Journal of Pharmacology and Experimental Therapeutics.

mixed meal in type 2 diabetes Regulation of endogenous glucose production after a

Yvonne, Katherine A. Winters, C. Cobelli, 2002 .